Company Overview of Metaclipse Therapeutics Corporation
Metaclipse Therapeutics Corporation operates as an early-stage biotechnology company that develops novel cancer therapies. The company manufactures and supplies modified tumor-membrane vesicles that are used to activate body’s immune system to mount attacks against metastatic cancer cells. Its products are used in the treatment of various cancer types, such as breast cancer, prostate cancer, renal cancer, melanoma, lymphoma, and ovarian. Metaclipse Therapeutics Corporation was founded in 2010 and is based in Atlanta, Georgia.
3175 Presidential Drive
Atlanta, GA 30340-3907
Founded in 2010
Key Executives for Metaclipse Therapeutics Corporation
Similar Private Companies By Industry
|ISTO Technologies, Inc.||United States|
|Targeted Diagnostics & Therapeutics, Inc.||United States|
|Predictive Biomarker Sciences, Inc.||United States|
|Reviva Pharmaceuticals Inc.||United States|
|Visionary Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Metaclipse Therapeutics Corporation, please visit www.metaclipsetherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.